Exponent Q3 revenue before reimbursements rises; raises 2026 outlook
EXPO•Exponent's fiscal third-quarter revenue before reimbursements rose 12% year over year, while net income was $30.9 million and diluted EPS was $0.64. The company raised its 2026 revenue growth outlook to 10%-11%.
1. Quarterly results
Exponent said revenue before reimbursements grew 12% year over year in fiscal Q3, with net income of $30.9 million and diluted EPS of $0.64. EBITDA was $45 million. User research and increased demand for dispute-related and failure analysis services supported growth.
2. Raised 2026 outlook
The company raised its full-year 2026 revenue growth guidance to 10%-11% over 2025 and expects EBITDA to be 28.0%-28.3% of revenue before reimbursements. For Q4 2026, it anticipates revenue growth of 8%-10% and an EBITDA margin of 26.3%-26.8%.
